Active substance
Dimeticone
- Health Canada 7
- UK MHRA 2
- NHS prices 3
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| CAVILON DURABLE BARRIER CREAM | 02455838 | 1.3 % / W/W | CREAM · TOPICAL | SOLVENTUM CANADA LIMITED |
| CICAPLAST BAUME B5 CONDITIONING PRO-VITAMIN B5 PRO-VITAMINE B5 REVITALISANTE | 02527731 | 9 % / W/W | CREAM · TOPICAL | LABORATOIRES LA ROCHE-POSAY CANADA |
| COMFORT SHIELD | 02245871 | 3 % | WIPE · TOPICAL | SAGE PRODUCTS LLC |
| DIMETHICONE PROTECTANT | 02301725 | 5.0 % / W/W | CREAM · TOPICAL | SMITH & NEPHEW INC |
| MEDLINE REMEDY ESSENTIALS CLEANSE BAZA CLEANSE & PROTECT | 02243966 | 2 % / W/W | LOTION · TOPICAL | MEDLINE INDUSTRIES, LP |
| NYDA | 02373785 | 50 % | SOLUTION · TOPICAL | G POHL-BOSKAMP GMBH & CO KG |
| PROSHIELD PLUS | 02256975 | 1 % / W/W | OINTMENT · TOPICAL | SMITH & NEPHEW INC |
UK MHRA United Kingdom — marketing authorisations
| Product | Authorisation | Holder | Legal status |
|---|---|---|---|
| HEDRIN 4% CUTANEOUS SOLUTION | PL 00240/0137 | THORNTON & ROSS LIMITED | GSL |
| HEDRIN 4% CUTANEOUS SOLUTION | PL 00240/0345 | THORNTON & ROSS LIMITED | P |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Dimeticone 4% cutaneous spray | £10.30 | 120 ml | 1 Oct 2026 |
| NHS Drug Tariff | Dimeticone 4% lotion | £4.36 | 50 ml | 1 Oct 2026 |
| NHS Drug Tariff | Dimeticone 4% lotion | £10.00 | 150 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Combinations containing Dimeticone
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.